238 related articles for article (PubMed ID: 12907674)
21. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis.
Huang F; Sorkin A
Mol Biol Cell; 2005 Mar; 16(3):1268-81. PubMed ID: 15635092
[TBL] [Abstract][Full Text] [Related]
22. Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation.
Mosesson Y; Shtiegman K; Katz M; Zwang Y; Vereb G; Szollosi J; Yarden Y
J Biol Chem; 2003 Jun; 278(24):21323-6. PubMed ID: 12719435
[TBL] [Abstract][Full Text] [Related]
23. Targeting E3 ubiquitin ligases for cancer therapy.
Sun Y
Cancer Biol Ther; 2003; 2(6):623-9. PubMed ID: 14688465
[TBL] [Abstract][Full Text] [Related]
24. Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors.
Bao J; Gur G; Yarden Y
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2438-43. PubMed ID: 12604776
[TBL] [Abstract][Full Text] [Related]
25. The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53.
Boutell C; Everett RD
J Biol Chem; 2003 Sep; 278(38):36596-602. PubMed ID: 12855695
[TBL] [Abstract][Full Text] [Related]
26. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
Joazeiro CA; Wing SS; Huang H; Leverson JD; Hunter T; Liu YC
Science; 1999 Oct; 286(5438):309-12. PubMed ID: 10514377
[TBL] [Abstract][Full Text] [Related]
27. Negative regulation of Lck by Cbl ubiquitin ligase.
Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation.
Lévy F; Muehlethaler K; Salvi S; Peitrequin AL; Lindholm CK; Cerottini JC; Rimoldi D
Mol Biol Cell; 2005 Apr; 16(4):1777-87. PubMed ID: 15703212
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
de Melker AA; van der Horst G; Borst J
J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Itch and Nedd4 E3 Ligase Activity and Degradation by LRAD3.
Noyes NC; Hampton B; Migliorini M; Strickland DK
Biochemistry; 2016 Mar; 55(8):1204-13. PubMed ID: 26854353
[TBL] [Abstract][Full Text] [Related]
31. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation.
Rao N; Ghosh AK; Ota S; Zhou P; Reddi AL; Hakezi K; Druker BK; Wu J; Band H
EMBO J; 2001 Dec; 20(24):7085-95. PubMed ID: 11742985
[TBL] [Abstract][Full Text] [Related]
32. Allosteric auto-inhibition and activation of the Nedd4 family E3 ligase Itch.
Zhu K; Shan Z; Chen X; Cai Y; Cui L; Yao W; Wang Z; Shi P; Tian C; Lou J; Xie Y; Wen W
EMBO Rep; 2017 Sep; 18(9):1618-1630. PubMed ID: 28747490
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners.
O'Connor HF; Lyon N; Leung JW; Agarwal P; Swaim CD; Miller KM; Huibregtse JM
EMBO Rep; 2015 Dec; 16(12):1699-712. PubMed ID: 26508657
[TBL] [Abstract][Full Text] [Related]
34. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.
Kavsak P; Rasmussen RK; Causing CG; Bonni S; Zhu H; Thomsen GH; Wrana JL
Mol Cell; 2000 Dec; 6(6):1365-75. PubMed ID: 11163210
[TBL] [Abstract][Full Text] [Related]
35. Grb10 prevents Nedd4-mediated vascular endothelial growth factor receptor-2 degradation.
Murdaca J; Treins C; Monthouël-Kartmann MN; Pontier-Bres R; Kumar S; Van Obberghen E; Giorgetti-Peraldi S
J Biol Chem; 2004 Jun; 279(25):26754-61. PubMed ID: 15060076
[TBL] [Abstract][Full Text] [Related]
36. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.
Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY
Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835
[TBL] [Abstract][Full Text] [Related]
37. Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl.
Grossmann AH; Kolibaba KS; Willis SG; Corbin AS; Langdon WS; Deininger MW; Druker BJ
FEBS Lett; 2004 Nov; 577(3):555-62. PubMed ID: 15556646
[TBL] [Abstract][Full Text] [Related]
38. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.
Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I
J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412
[TBL] [Abstract][Full Text] [Related]
39. The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases.
Sanjay A; Horne WC; Baron R
Sci STKE; 2001 Nov; 2001(110):pe40. PubMed ID: 11724969
[TBL] [Abstract][Full Text] [Related]
40. Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.
Kim M; Tezuka T; Tanaka K; Yamamoto T
Oncogene; 2004 Mar; 23(9):1645-55. PubMed ID: 14661060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
